Risk factors for the development of depression in patients with hepatitis C taking interferon-α
Kimberley J Smith¹, Suzanne Norris², Cliona O'Farrelly³, O'Mara SM¹¹Trinity College Institute of Neuroscience, ²Hepatology Centre, St James's Hospital, Dublin, Ireland; ³Dep...
Guardado en:
Autores principales: | Smith KJ, Norris S, O'Farrelly C, O'Mara SM |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Dove Medical Press
2011
|
Materias: | |
Acceso en línea: | https://doaj.org/article/ef8d14a5849a42ac8d14a5a57306ff39 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Did depressive symptoms affect recognition of emotional prosody in Parkinson’s disease?
por: Adriana Vélez Feijó, et al.
Publicado: (2008) -
Balance and gait in older electroconvulsive therapy recipients: a pilot study
por: Plakiotis C, et al.
Publicado: (2013) -
Trazodone effects on [3H]-paroxetine and α2-adrenoreceptors in platelets of patients with major depression
por: Donatella Marazziti, et al.
Publicado: (2010) -
Duloxetine in panic disorder with somatic gastric pain
por: Preve M, et al.
Publicado: (2013) -
Ceruloplasmin and iron in Alzheimer’s disease and Parkinson’s disease: a synopsis of recent studies
por: Kristinsson J, et al.
Publicado: (2012)